HALF-YEAR FINANCIAL REPORT
JUNE 30, 2023
DiaSorin S.p.A.
Via Crescentino (no building No.) - 13040 Saluggia (VC) Tax I.D. and Vercelli Company Register n. 13144290155
Contents | |
........................................................................................ 3 | |
4. OUR BUSINESS | 6 |
THE GROUP'S TECHNOLOGIES | |
1. IMMUNODIAGNOSTICS | 7 |
2. MOLECULAR DIAGNOSTICS | 7 |
3. LICENSED TECHNOLOGIES | 9 |
4. RESEARCH AND DEVELOPMENT | 9 |
OVERVIEW OF THE RESULTS | |
1 CONSOLIDATED FINANCIAL HIGHLIGHTS | 11 |
2. OVERVIEW OF THE GROUP'S PERFORMANCE IN THE FIRST HALF OF 2023 AND COMPARISON WITH 2022
................................................................................................................................................................ | 12 | |
3. REVIEW OF THE GROUP'S OPERATING PERFORMANCE AND FINANCIAL POSITION | 15 | |
4. STATEMENT OF FINANCIAL POSITION AT JUNE 30, 2023 | 20 | |
5. TRANSACTIONS RESULTING FROM NON-RECURRING, ATYPICAL AND/OR UNUSUAL OPERATIONS .... | 23 | |
6. MAIN RISKS AND UNCERTAINTIES TO WHICH DIASORIN S.P.A AND THE GROUP ARE EXPOSED | 23 | |
7. SIGNIFICANT EVENTS OCCURRED AFTER JUNE 30, 2023 AND BUSINESS OUTLOOK | 26 | |
8. RELATED-PARTYTRANSACTIONS | 26 | |
CONDENSED HALF-YEAR CONSOLIDATED FINANCIAL | ||
STATEMENTS AT JUNE 30, 2023 | ||
1. | CONSOLIDATED INCOME STATEMENT | 27 |
2. | CONSOLIDATED COMPREHENSIVE INCOME STATEMENT | 28 |
3. | CONSOLIDATED STATEMENT OF FINANCIAL POSITION | 29 |
4. | CONSOLIDATED STATEMENT OF CASH FLOWS | 31 |
5. | STATEMENT OF CHANGES IN CONSOLIDATED SHAREHOLDERS' EQUITY | 32 |
6. | NOTES TO THE CONDENSED HALF-YEAR CONSOLIDATED FINANCIAL STATEMENTS | 33 |
7. | ANNEX I: THE COMPANIES OF THE DIASORIN GROUP AT JUNE 30, 2023 | 60 |
8. CERTIFICATION TO THE CONDENSED HALF-YEAR CONSOLIDATED FINANCIAL
STATEMENTS | 61 |
2
DIASORIN WORLD
1. BOARD OF DIRECTORS & CONTROL BODIES
BOARD OF DIRECTORS (appointed on April 29, 2022)
Chairman | Michele Denegri |
Deputy Chairman | Giancarlo Boschetti |
Chief Executive Officer | Carlo Rosa (1) |
Directors | Chen Menachem Even |
Stefano Altara | |
Luca Melindo | |
Diego Pistone | |
Fiorella Altruda (2) | |
André Michel Ballester (2)(3) | |
Franco Moscetti | |
Francesca Pasinelli (2) | |
Roberta Somati (2) | |
Monica Tardivo (2) | |
Tullia Todros (2) | |
Giovanna Pacchiana Parravicini (2) | |
BOARD OF STATUTORY AUDITORS | |
Chairman | Monica Mannino |
Statutory Auditors | Ottavia Alfano |
Matteo Michele Sutera | |
Alternates | Romina Guglielmetti |
Cristian Tundo | |
INDEPENDENT AUDITORS | PricewaterhouseCoopers S.p.A. |
COMMITTEES | |
Control, Risk and Sustainability Committee | André Michel Ballester (2) (Chairman) |
Franco Moscetti | |
Roberta Somati (2) | |
Remuneration and Nominating Committee | Roberta Somati (2) |
Giancarlo Boschetti | |
Giovanna Pacchiana Parravicini (2) | |
Committee for Related-Party Transactions | Roberta Somati (2) |
André Michel Ballester (2) | |
Giovanna Pacchiana Parravicini (2) | |
(1) General Manager | |
(2) Independent Director | |
(3) Lead Independent Director | |
3 |
2. DIASORIN WORLDWIDE
The Group headed by DiaSorin S.p.A. operates in all continents through 39 Companies, 4 branches, 10 production sites and 9 research and development centers located around the world.
DiaSorin operates, through its direct presence, in 27 countries. The rest of the world is served through an international network of independent distributors with whom the Group maintains a constant dialogue in accordance with the best interests of its end customers.
4
3. THE DIASORIN GROUP
5
Attachments
- Original Link
- Original Document
- Permalink
Disclaimer
DiaSorin S.p.A. published this content on 03 August 2023 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 22 August 2023 19:39:00 UTC.